| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SLC8A1_0005300 | Exon-Exon | chr2:40387905-40397489 | chr2:40160765-40170349 | 300 nt | 0.4767 |
| hsa_SLC8A1_0005400 | Exon-Exon | chr2:40387905-40404995 | chr2:40160765-40177855 | 437 nt | 0.4485 |
| hsa_SLC8A1_0006100 | Exon-Exon | chr2:40387905-40405633 | chr2:40160765-40178493 | 461 nt | 0.4577 |
| hsa_SLC8A1_0007100 | Exon-Exon | chr2:40391994-40405633 | chr2:40164854-40178493 | 361 nt | 0.4571 |
| hsa_SLC8A1_0007800 | Exon-Exon | chr2:40402401-40657444 | chr2:40175261-40430304 | 1960 nt | 0.4357 |
| hsa_SLC8A1_0014200 | Intron-Intron | chr2:40543761-40543898 | chr2:40316621-40316758 | 138 nt | 0.4058 |
| hsa_SLC8A1_0017000 | Intron-Intron | chr2:40580510-40580836 | chr2:40353370-40353696 | 327 nt | 0.4037 |
| hsa_chr2_0768300 | Intergenic-Intergenic | chr2:40586994-40587125 | chr2:40359854-40359985 | 132 nt | 0.2955 |
| hsa_SLC8A1_0017900 | Intron-Intron | chr2:40595005-40595202 | chr2:40367865-40368062 | 198 nt | 0.3586 |
| hsa_SLC8A1_0021700 | Exon-Exon | chr2:40655613-40657441 | chr2:40428473-40430301 | 1829 nt | 0.4363 |
A study in rats and H9c2 cells demonstrated that the circSLC8A1 is upregulated in ischemic heart disease models [Tian et al. DOI:10.1038/s41598-021-84056-5]. Furthermore, research in human peripheral blood confirmed the circSLC8A1 is significantly upregulated in myocardial infarction patients and exhibits high diagnostic value as a biomarker [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in mice demonstrated that the circSLC8A1 (mmu_circ_004295) is increased with ischemia time in the heart and promotes cardiomyocyte apoptosis by acting as an endogenous miR-133a-3p sponge [Tian et al. DOI:10.3390/molecules26041155].